Safety and effectiveness of ibutilide in a community hospital

Pharmacotherapy

Volumn 21, Issue 4, 2001, Pages 488-492

  Taylor, Charles T ^a,b   Donaldson, Amy R ^a,c  

^a AUBURN UNIVERSITY   (United States)

^b UNIVERSITY OF ALABAMA   (United States)

^c Rural Alabama Area Health Education Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IBUTILIDE FUMARATE;

AGED; ARTICLE; BRADYCARDIA; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; PATIENT MONITORING; QT INTERVAL;

AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; FEMALE; HOSPITALS, COMMUNITY; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SULFONAMIDES;

EID: 0035066554     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.21.5.488.34496     Document Type: Article

References (7)

1. Ibutilide: A new class III antiarrhythmic agent
2. Ibutilide
3. Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery
4. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation
5. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation
6. Acute management of atrial fibrillation and atrial flutter in the critical care unit: Should it be ibutilide?
7. Safety and risk/benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutter